Not Yet Recruiting NA INTERVENTIONAL 1-arm NCT06355921

A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors (RFAdesmoid)

Sponsor: Blokhin's Russian Cancer Research Center

Conditions Desmoid Desmoid Fibromatosis Desmoid Tumor

Updated 4 times since 2024 Last updated: Apr 3, 2024 Started: Apr 1, 2024 Primary completion: Feb 1, 2026 Completion: May 1, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Desmoid and Desmoid Fibromatosis, this trial is actively recruiting participants. The trial is conducted by Blokhin's Russian Cancer Research Center and has accumulated 4 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Not Yet Recruiting NA
Sep 2024 — Sep 2025 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
May 2024 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Apr 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Blokhin's Russian Cancer Research Center

Data source: Blokhin's Russian Cancer Research Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Moscow, Russia